Pregnancy complications associated with hepatitis C: data from a 2003-2005 Washington state birth cohort

American Journal of Obstetrics and Gynecology

Volumn 199, Issue 1, 2008, Pages 38.e1-38.e9

  Pergam, Steven A ^a   Wang, Chia C ^a   Gardella, Carolyn M ^a   Sandison, Taylor G ^a   Phipps, Warren T ^a   Hawes, Stephen E ^a  

^a UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

Author keywords

drug use; gestational diabetes; hepatitis C; pregnancy complications

Indexed keywords

ADULT; ARTICLE; ARTIFICIAL VENTILATION; BIRTH CERTIFICATE; COHORT ANALYSIS; CONFIDENCE INTERVAL; CONTROLLED STUDY; DATA ANALYSIS; DRUG USE; FEMALE; HEPATITIS C; HEPATITIS C VIRUS; HOSPITAL ADMISSION; HUMAN; INFORMATION PROCESSING; LOW BIRTH WEIGHT; MEDICAL RECORD; NEWBORN; NEWBORN INTENSIVE CARE; PREGNANCY COMPLICATION; PREGNANCY DIABETES MELLITUS; PREGNANCY OUTCOME; PRIORITY JOURNAL; RISK; WEIGHT GAIN;

EID: 45649083859     PISSN: 00029378     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ajog.2008.03.052     Document Type: Article

References (48)

1. Global surveillance and control of hepatitis C. Report of a WHO Consultation organized in collaboration with the Viral Hepatitis Prevention Board, Antwerp, Belgium. J Viral Hepat 6 (1999) 35-47
2. Alter M.J., Kruszon-Moran D., Nainan O.V., et al. The prevalence of hepatitis C virus infection in the United States, 1988 through 1994. N Engl J Med 341 (1999) 556-562
3. Marranconi F., Fabris P., Stecca C., et al. Prevalence of anti-HCV and risk factors for hepatitis C virus infection in healthy pregnant women. Infection 22 (1994) 333-337
4. Marcellin P., Bernuau J., Martinot-Peignoux M., et al. Prevalence of hepatitis C virus infection in asymptomatic anti-HIV1 negative pregnant women and their children. Dig Dis Sci 38 (1993) 2151-2155
5. Conte D., Fraquelli M., Prati D., et al. Prevalence and clinical course of chronic hepatitis C virus (HCV) infection and rate of HCV vertical transmission in a cohort of 15,250 pregnant women. Hepatology 31 (2000) 751-755
6. Baldo V., Floreani A., Menegon T., et al. Hepatitis C virus, hepatitis B virus and human immunodeficiency virus infection in pregnant women in North-East Italy: A seroepidemiological study. Eur J Epidemiol 16 (2000) 87-91
7. Silverman N.S., Jenkin B.K., Wu C., et al. Hepatitis C virus in pregnancy: Seroprevalence and risk factors for infection. Am J Obstet Gynecol 169 (1993) 583-587
8. Leikin E.L., Reinus J.F., Schmell E., et al. Epidemiologic predictors of hepatitis C virus infection in pregnant women. Obstet Gynecol 84 (1994) 529-534
9. Goldberg D., McIntyre P.G., Smith R., et al. Hepatitis C virus among high and low risk pregnant women in Dundee: Unlinked anonymous testing. BJOG 108 (2001) 365-370
10. Baeten J.M., Bukusi E.A., and Lambe M. Pregnancy complications and outcomes among overweight and obese nulliparous women. Am J Public Health 91 (2001) 436-440
11. Burns L., Mattick R.P., and Cooke M. The use of record linkage to examine illicit drug use in pregnancy. Addiction 101 (2006) 873-882
12. Kennare R., Heard A., and Chan A. Substance use during pregnancy: risk factors and obstetric and perinatal outcomes in South Australia. Aust N Z J Obstet Gynaecol 45 (2005) 220-225
13. Kotelchuck M. An evaluation of the Kessner Adequacy of Prenatal Care Index and a proposed Adequacy of Prenatal Care Utilization Index. Am J Public Health 84 (1994) 1414-1420
14. Lydon-Rochelle M.T., Holt V.L., Cardenas V., et al. The reporting of pre-existing maternal medical conditions and complications of pregnancy on birth certificates and in hospital discharge data. Am J Obstet Gynecol 193 (2005) 125-134
15. Centers for Disease Control and Prevention. BMI-body mass index: About BMI for adults. 2006. http://www.cdc.gov/nccdphp/dnpa/bmi/adult_BMI/about_adult_BMI.htm Accessed May 10, 2006
16. Institute of Medicine, Food and Nutrition Board, Committee on Nutritional Status During Pregnancy, part I. Nutritional status and weight gain (1990), National Academy Press, Washington (DC)
17. Edwards L.E., Hellerstedt W.L., Alton I.R., et al. Pregnancy complications and birth outcomes in obese and normal-weight women: Effects of gestational weight change. Obstet Gynecol 87 (1996) 389-394
18. Williams R.L., Creasy R.K., Cunningham G.C., et al. Fetal growth and perinatal viability in California. Obstet Gynecol 59 (1982) 624-632
19. Fraser G.M., Harman I., Meller N., et al. Diabetes mellitus is associated with chronic hepatitis C but not chronic hepatitis B infection. Isr J Med Sci 32 (1996) 526-530
20. Caronia S., Taylor K., Pagliaro L., et al. Further evidence for an association between non-insulin-dependent diabetes mellitus and chronic hepatitis C virus infection. Hepatology 30 (1999) 1059-1063
21. Gray H., Wreghitt T., Stratton I.M., et al. High prevalence of hepatitis C infection in Afro-Caribbean patients with type 2 diabetes and abnormal liver function tests. Diabet Med 12 (1995) 244-249
22. Allison M.E., Wreghitt T., Palmer C.R., et al. Evidence for a link between hepatitis C virus infection and diabetes mellitus in a cirrhotic population. J Hepatol 21 (1994) 1135-1139
23. Ozyilkan E., and Arslan M. Increased prevalence of diabetes mellitus in patients with chronic hepatitis C virus infection. Am J Gastroenterol 91 (1996) 1480-1481
24. Grimbert S., Valensi P., Levy-Marchal C., et al. High prevalence of diabetes mellitus in patients with chronic hepatitis C. A case-control study. Gastroenterol Clin Biol 20 (1996) 544-548
25. Mehta S.H., Brancati F.L., Strathdee S.A., et al. Hepatitis C virus infection and incident type 2 diabetes. Hepatology 38 (2003) 50-56
26. Mehta S.H., Brancati F.L., Sulkowski M.S., et al. Prevalence of type 2 diabetes mellitus among persons with hepatitis C virus infection in the United States. Ann Intern Med 133 (2000) 592-599
27. Shintani Y., Fujie H., Miyoshi H., et al. Hepatitis C virus infection and diabetes: direct involvement of the virus in the development of insulin resistance. Gastroenterology 126 (2004) 840-848
28. Hui J.M., Sud A., Farrell G.C., et al. Insulin resistance is associated with chronic hepatitis C virus infection and fibrosis progression [corrected]. Gastroenterology 125 (2003) 1695-1704
29. Lonardo A., Loria P., Adinolfi L.E., et al. Hepatitis C and steatosis: A reappraisal. J Viral Hepat 13 (2006) 73-80
30. Laskus T., Radkowski M., Wang L.F., et al. Search for hepatitis C virus extrahepatic replication sites in patients with acquired immunodeficiency syndrome: specific detection of negative-strand viral RNA in various tissues. Hepatology 28 (1998) 1398-1401
31. Kaaja R.J., and Greer I.A. Manifestations of chronic disease during pregnancy. JAMA 294 (2005) 2751-2757
32. Jabeen T., Cannon B., Hogan J., et al. Pregnancy and pregnancy outcome in hepatitis C type 1b. Q J Med 93 (2000) 597-601
33. Jaffery T., Tariq N., Ayub R., et al. Frequency of hepatitis C in pregnancy and pregnancy outcome. J Coll Physicians Surg Pak 15 (2005) 716-719
34. Floreani A., Paternoster D., Zappala F., et al. Hepatitis C virus infection in pregnancy. Br J Obstet Gynaecol 103 (1996) 325-329
35. Latt N.C., Spencer J.D., Beeby P.J., et al. Hepatitis C in injecting drug-using women during and after pregnancy. J Gastroenterol Hepatol 15 (2000) 175-181
36. Bohman V.R., Stettler R.W., Little B.B., et al. Seroprevalence and risk factors for hepatitis C virus antibody in pregnant women. Obstet Gynecol 80 (1992) 609-613
37. Medhat A., el-Sharkawy M.M., Shaaban M.M., et al. Acute viral hepatitis in pregnancy. Int J Gynaecol Obstet 40 (1993) 25-31
38. Ludlow J.P., Evans S.F., and Hulse G. Obstetric and perinatal outcomes in pregnancies associated with illicit substance abuse. Aust N Z J Obstet Gynaecol 44 (2004) 302-306
39. Redline R.W. Severe fetal placental vascular lesions in term infants with neurologic impairment. Am J Obstet Gynecol 192 (2005) 452-457
40. Sander C.M., Gilliland D., Akers C., et al. Livebirths with placental hemorrhagic endovasculitis: Interlesional relationships and perinatal outcomes. Arch Pathol Lab Med 126 (2002) 157-164
41. Colon H.M., Robles R.R., and Sahai H. The validity of drug use responses in a household survey in Puerto Rico: Comparison of survey responses of cocaine and heroin use with hair tests. Int J Epidemiol 30 (2001) 1042-1049
42. Colon H.M., Robles R.R., and Sahai H. The validity of drug use self-reports among hard core drug users in a household survey in Puerto Rico: Comparison of survey responses of cocaine and heroin use with hair tests. Drug Alcohol Depend 67 (2002) 269-279
43. Buchan B.J., L Dennis M., Tims F.M., et al. Cannabis use: Consistency and validity of self-report, on-site urine testing and laboratory testing. Addiction 97 Suppl 1 (2002) 98-108
44. Recommendations for prevention and control of hepatitis C virus (HCV) infection and HCV-related chronic disease. Centers for Disease Control and Prevention. MMWR Recomm Rep 47 (1998) 1-39
45. American College of Obstetricians and Gynecologists. Primary and preventive care: Periodic assessments. ACOG technical bulletin no. 246 (2000), American College of Obstetricians and Gynecologists, Washington (DC) p. 1-7
46. Plunkett B.A., and Grobman W.A. Routine hepatitis C virus screening in pregnancy: A cost-effectiveness analysis. Am J Obstet Gynecol 192 (2005) 1153-1161
47. Boaz K., Fiore A.E., Schrag S.J., et al. Screening and counseling practices reported by obstetrician-gynecologists for patients with hepatitis C virus infection. Infect Dis Obstet Gynecol 11 (2003) 39-44
48. Giles M.L., Sasadeusz J.J., Garland S.M., et al. An audit of obstetricians' management of women potentially infected with blood-borne viruses. Med J Aust 80 (2004) 328-332